No Data
Microtech Medical-B (02235.HK) plans to hold a Board of Directors meeting on March 28 to approve the annual performance.
Glory Financial reported on March 18 that Weitai Medical-B (02235.HK) announced that the Board of Directors meeting will be held on Friday, March 28, 2025, which includes reviewing and approving the annual performance of the company and its subsidiaries for the year ending December 31, 2024, as well as considering the proposal for the distribution of a final dividend (if any).
MICROTECH MED-B: NOTICE OF BOARD MEETING
Retail Investors Who Hold 26% of MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235) Gained 20%, Insiders Profited as Well
The new drug development time is cut in half, diagnoses are more accurate, industry barriers are lowered... AI is transforming the Medical Industry in China.
On February 26, Deutsche Bank Analyst Cyrus Ng released a report stating that the entire Medical Industry in China, from drug development and diagnostics to Hospital management, will benefit from the AI revolution.
The wave of AI in Medical is sweeping: the potential of the macromolecule new drug market is highlighted and imaging products are "going overseas" into Emerging Markets | Focus
① Some executives from pharmaceutical companies have stated that "currently, the discovery of small molecule drugs is very challenging; finding potential molecules and structures is already quite difficult, while there is still significant potential in the discovery and design of large molecule new drugs." ② Currently, the application maturity of AI technology in the imaging field is relatively high, and relevant manufacturers have revealed that the market potential for AI imaging large models in Belt and Road Initiative Concept countries is quite extensive.
Zhongsu Hong Kong Stock Repurchase Statistics | February 14
Hong Kong stock repurchase Statistics | February 14
